Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-10

Clinical Trial Update: Distress Tolerance and Buprenorphine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial studying distress tolerance with buprenorphine for opioid dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Butler Hospital | Conditions: Opioid Dependence | Phase 3 | Status: COMPLETED